Hospitals can negotiate acceptable rates and still lose revenue through underpayment, denial friction, carve-outs, contract configuration, site-of-service rules, and weak renewal sequencing. This diagnostic shows where the loss is occurring, which payer or service line matters most, and what leadership should address first.
Rate negotiation answers one question: what the payer agreed to pay. It does not answer the question finance actually needs answered — what the organization is being paid, on which services, under which conditions, and at what administrative cost.
Realized yield sits between the contract and the remittance. It is shaped by payment variance, downcoding and bundling behavior, edits and carve-outs, site-of-service rules, system configuration, documentation quality, and the volume of rework required to collect what was already earned. Each of these has a different owner and a different fix, which is why an unranked list of problems rarely changes margin.
Contract yield is an executive-level lever, not a back-office cleanup task. Ardent Health has publicly described a payer renewal — supported by integrated contracting, revenue integrity, and price-transparency benchmarking — as expected to add $5M–$10M to its 2026 adjusted EBITDA. That is cited only as a real-world signal that contract yield can reach the earnings statement; it is not a ClinEfficiency Pro result and not a projection of your outcome. Source: Becker's Hospital Review
Expected reimbursement under the contract compared against what was actually paid, by payer, plan, and service. Variance is separated from normal case-mix movement so leadership sees real yield loss rather than noise.
Recurring underpayment behaviors, downcoding, bundling and edit-driven reductions, and the denial and rework patterns that delay or erode otherwise payable revenue.
Where yield loss concentrates by payer, market, site of service, and service line — so remediation effort follows financial materiality rather than complaint volume.
Operational review of rate exhibits, carve-outs, implant and drug provisions, site-of-service rules, escalators, and configuration in the contract-management and billing systems. Operational analysis, not legal advice.
Published payer-specific and market rate disclosures used as directional positioning signals for the contracts and service lines under review.
Modeled outcomes across rate, term, language, and configuration changes, sequenced against the renewal calendar so executive attention lands on the negotiations that carry the most margin.
Which payer is creating the largest avoidable margin loss?
Is the problem the contracted rate, payer payment behavior, denial friction, or our own workflow?
Which service lines and sites of service are most exposed?
Which renewal deserves executive attention first?
What can be corrected internally before we return to the negotiating table?
Fixed scope by one payer, one market, or one defined service-line cohort. Additional payers, markets, or cohorts are scoped as separate increments.
$25,000–$75,000 per payer, market, or defined service-line cohort, depending on data volume, number of contracts and payers, markets in scope, and service-line breadth.
Defined during scoping, based on data availability and the number of contracts in scope.
Relevant contracts and rate exhibits, remittance and payment data, denial and underpayment data, service-line volume, payer mix, and the renewal calendar. Minimum viable scope can be defined during discovery if some inputs are incomplete.
This is an operational, financial, and reimbursement analysis. It is not legal advice, not a contingency recovery service, and it does not guarantee a specific amount of recovered or renegotiated revenue.
Bring the payer, market, or service-line cohort under the most margin pressure. We will define the data set, confirm minimum viable scope, and set the engagement range and timeline before any work begins.